US$500,000,000
The Company also proposes to issue and sell to the several Underwriters, in aggregate, not more than an additional US$75,000,000 principal amount of such securities (the “Additional Securities”) if and to the extent that you shall have determined to exercise, on behalf of the Underwriters, the right to purchase such securities granted to the Underwriters pursuant to
Subject to the terms and conditions and in reliance upon the representations and warranties set forth herein, the Company agrees to sell to each Underwriter, and each Underwriter agrees, severally and not jointly, to purchase from the Company the principal amount of the Firm Securities set forth opposite such Underwriter’s name in Schedule II hereto, at the purchase price of 96.85% (being equal to the issue price of 100% less a gross spread of 3.15% representing a combined sales concession, management commission and underwriters’ commission) of the principal amount of the Securities plus accrued interest, if any, from January 31, 2012 if settlement occurs after that date; provided that in the case of sales by an Underwriter to certain institutions, the purchase price per Firm Security shall be an amount equal to 98.00% of the principal amount of the Firm Securities so sold (being equal to the issue price of 100% less a gross spread of 2.00% representing a combined sales concession, management commission and underwriters’ commission).
Subject to the terms and conditions and in reliance upon the representations and warranties set forth herein, the Company agrees to sell to the Underwriters the Additional Securities, and the Underwriters shall have the right to purchase, severally and not jointly, up to US$75,000,000 aggregate principal amount of Additional Securities at the purchase price as described in the paragraph immediately above.
On each day, if any, that Additional Securities are purchased (each an “Option Closing Date”), each Underwriter agrees, severally and not jointly, to purchase the aggregate principal amount of Additional Securities that bears the same proportion to the aggregate principal amount of Additional Securities to be purchased on such Option Closing Date as the number of Firm Securities set forth in Schedule II hereto opposite the name of such Underwriter bears to the total number of Firm Securities, subject to such adjustments as the Representatives, in their discretion, may make to eliminate any sales or purchases of a fractional aggregate principal amount of Additional Securities plus any additional principal amount of Securities which such underwriters may become obligated to purchase pursuant to the provisions of Section 10 hereof.
Payment and Delivery.
Payment for the Firm Securities shall be made to the Company in immediately available funds in New York, New York against delivery of such Firm Securities for the respective accounts of the several Underwriters by 10:00 am, New York time, on January 31, 2012, or at such other time on the same or such later date not more than three business days after that date as shall be designated in writing by you, which time and date may be postponed by agreement between the Representatives and the Company or as provided in Section 10.
Payment for any Additional Securities shall be made to the Company in immediately available funds in New York, New York against delivery of such Additional Securities for the respective accounts of the several Underwriters at 10:00 am, New York time, on the Option Closing Date specified in the corresponding notice described in Section 2 or at such other time on the same or on such other date, in any event not later than three business days after the date, as shall be designated in writing by you.
If the United States dollars so purchased are greater than the sum originally due to such Underwriter or controlling person hereunder, such Underwriter or controlling person agrees to pay to the Company an amount equal to the excess of the dollars so purchased over the sum originally due to such Underwriter or controlling person hereunder.
8.000% Non-Cumulative Subordinated Notes due 2042
US$500,000,000 (excluding the underwriters’ option to purchase up to US$75,000,000 of additional aggregate principal amount of Non-Cumulative Subordinated Notes to cover overallotments, if any)
US$25 and integral multiples thereof
8.000%
$25 per Non-Cumulative Subordinated Note
$0.7875 per Non-Cumulative Subordinated Note for retail orders $0.5000 per Non-Cumulative Subordinated Note for institutional orders
$24.2264 per Non-Cumulative Subordinated Note.
$484,528,875, not including proceeds, if any, from the exercise of the Overallotment Option
INTEREST PAYMENT DATES:
Callable at par plus accrued and unpaid interest on August 15, 2017 or any Interest Payment Date thereafter
102,187,500
102,187,500
102,187,500
102,187,500
25,000,000
8,750,000
8,750,000
8,750,000
8,750,000
2,500,000
2,500,000
2,500,000
2,500,000
2,500,000
2,500,000
1,250,000
1,250,000
1,250,000
1,250,000
1,250,000
1,250,000
1,250,000
1,250,000
1,250,000
1,250,000
1,250,000
1,250,000
1,250,000
500,000,000
Re:         Offer by AEGON N.V. (the “Company”) of US$500,000,000 aggregate principal amount of Securities (as such term is defined in the Underwriting Agreement)
We have acted as legal counsel on matters of Netherlands law to the Company in connection with the offer for sale by the Company of US$500,000,000 aggregate principal amount of Securities pursuant to an underwriting agreement among the Company and the Underwriters, dated January 24, 2012 (the “Underwriting Agreement”).
Offering of $500,000,000 aggregate principal amount of 8.000% Non-Cumulative Subordinated Notes due 2042 (the “Securities”) by AEGON N.V.
Offering of US$500,000,000 aggregate principal amount of Securities by AEGON N.V.
Re:         Aegon N.V. – 8.000% Non-Cumulative Subordinated Notes due 2042
